Twist Bioscience Corp (TWST) is ready for next Episode as it posted an annual sales of 312,970 K

Twist Bioscience Corp (NASDAQ: TWST) kicked off on Friday, up 6.06% from the previous trading day, before settling in for the closing price of $36.63. Over the past 52 weeks, TWST has traded in a range of $27.41-$60.90.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has jumped its sales by 42.89% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 43.47%. With a float of $56.37 million, this company’s outstanding shares have now reached $59.58 million.

In an organization with 923 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 44.59%, operating margin of -63.15%, and the pretax margin is -59.59%.

Twist Bioscience Corp (TWST) Insider Updates

Our next focus will be how large-scale investors are participating in this stock of the Diagnostics & Research Industry. The insider ownership of Twist Bioscience Corp is 5.50%, while institutional ownership is 107.00%. The most recent insider transaction that took place on Apr 09 ’25, was worth 88,887. Before that another transaction happened on Apr 02 ’25, when Company’s insider sold 124 for $38.73, making the entire transaction worth $4,803. This insider now owns 111,538 shares in total.

Twist Bioscience Corp (TWST) Performance Highlights and Predictions

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.55 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 43.47% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.54% during the next five years compared to 1.70% growth over the previous five years of trading.

Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators

Take a look at Twist Bioscience Corp’s (TWST) current performance indicators. Last quarter, stock had a quick ratio of 4.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 7.02.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.38, a number that is poised to hit -0.55 in the next quarter and is forecasted to reach -1.50 in one year’s time.

Technical Analysis of Twist Bioscience Corp (TWST)

Let’s dig in a bit further. During the last 5-days, its volume was 1.77 million. That was better than the volume of 1.08 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 66.27%. Additionally, its Average True Range was 3.83.

During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 25.66%, which indicates a significant decrease from 48.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 83.73% in the past 14 days, which was higher than the 67.61% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $42.51, while its 200-day Moving Average is $45.61. However, in the short run, Twist Bioscience Corp’s stock first resistance to watch stands at $40.14. Second resistance stands at $41.44. The third major resistance level sits at $43.47. If the price goes on to break the first support level at $36.81, it is likely to go to the next support level at $34.78. Assuming the price breaks the second support level, the third support level stands at $33.48.

Twist Bioscience Corp (NASDAQ: TWST) Key Stats

The company with the Market Capitalisation of 2.32 billion has total of 59,651K Shares Outstanding. Its annual sales at the moment are 312,970 K in contrast with the sum of -208,730 K annual income. Company’s last quarter sales were recorded 88,710 K and last quarter income was -31,590 K.